Proxima vs Biconomy

Side-by-side comparison of AI visibility scores, market position, and capabilities

Proxima leads in AI visibility (31 vs 20)
Proxima logo

Proxima

EmergingHealthcare & Life Sciences

AI Protein Drug Design

AI drug discovery for protein-protein interactions; raised $80M seed from DCVC and NVIDIA (Jan 2026); oncology and neurodegeneration focus; opens class of previously undruggable targets

AI VisibilityBeta
Overall Score
D31
Category Rank
#1 of 1
AI Consensus
57%
Trend
up
Per Platform
ChatGPT
41
Perplexity
41
Gemini
24

About

Proxima is an AI-driven drug discovery company focused on proteins that control critical biological interactions — specifically targeting protein-protein interactions (PPIs) that have historically been considered undruggable. Founded by researchers with backgrounds in structural biology, machine learning, and medicinal chemistry, Proxima uses AI to design novel therapeutics that can modulate these complex binding interfaces, opening up a vast new class of drug targets for conditions ranging from cancer to neurodegeneration.\n\nThe company's platform integrates protein structure prediction, generative molecular design, and experimental validation in a tightly coupled loop. By leveraging AI models trained on structural and interaction data, Proxima can propose drug candidates targeting previously inaccessible sites on proteins. This approach is particularly relevant for oncology and immunology, where many of the most important biological pathways are mediated by protein complexes that small molecules have struggled to disrupt.\n\nProxima raised an $80M seed round backed by DCVC and NVIDIA in January 2026, one of the largest seed rounds in biotech history. NVIDIA's involvement underscores the computational intensity of the platform and the strategic value of GPU infrastructure partnerships in AI drug discovery. The company is pre-clinical but is building a pipeline of candidates targeting high-value undruggable proteins, with the $80M runway intended to advance multiple programs toward IND filings.

Full profile
Biconomy logo

Biconomy

EmergingWeb3

Web3 Transaction Infrastructure

Web3 authentication and account abstraction infrastructure enabling gasless transactions and simplified dApp onboarding; ERC-4337 implementation allows dApps to sponsor gas fees on behalf of users and accept ERC-20 token gas payment for mainstream-accessible wallet experiences.

AI VisibilityBeta
Overall Score
D20
Category Rank
#1 of 1
AI Consensus
55%
Trend
up
Per Platform
ChatGPT
13
Perplexity
26
Gemini
13

About

Biconomy is a Web3 infrastructure platform focused on making decentralized applications usable by mainstream audiences who are not familiar with cryptocurrency gas mechanics. Its core product implements account abstraction via ERC-4337, allowing dApp developers to sponsor gas fees on behalf of users, accept gas payment in ERC-20 tokens instead of native currency, and batch multiple on-chain transactions into a single user action. These capabilities transform the user experience from one requiring native token balances and technical awareness into something closer to a conventional web application workflow.

Full profile

AI Visibility Head-to-Head

31
Overall Score
20
#1
Category Rank
#1
57
AI Consensus
55
up
Trend
up
41
ChatGPT
13
41
Perplexity
26
24
Gemini
13
39
Claude
28
37
Grok
15

Capabilities & Ecosystem

Capabilities

Only Proxima
AI Protein Drug Design
Only Biconomy
Web3 Transaction Infrastructure

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.